PortfoliosLab logoPortfoliosLab logo
NN vs. NVS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

NN vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NextNav Inc. (NN) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

NN vs. NVS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
NN
NextNav Inc.
-3.73%6.94%249.66%51.88%-66.55%-19.34%
NVS
Novartis AG
14.16%46.95%0.02%16.14%8.06%4.99%

Fundamentals

Market Cap

NN:

$2.13B

NVS:

$294.65B

EPS

NN:

-$1.37

NVS:

$7.20

PS Ratio

NN:

484.30

NVS:

5.29

Total Revenue (TTM)

NN:

$4.57M

NVS:

$56.15B

Gross Profit (TTM)

NN:

-$2.98M

NVS:

$41.12B

EBITDA (TTM)

NN:

-$139.76M

NVS:

$22.99B

Returns By Period

In the year-to-date period, NN achieves a -3.73% return, which is significantly lower than NVS's 14.16% return.


NN

1D
4.91%
1M
-0.44%
YTD
-3.73%
6M
12.03%
1Y
31.64%
3Y*
99.09%
5Y*
10Y*

NVS

1D
1.59%
1M
-6.65%
YTD
14.16%
6M
22.74%
1Y
41.19%
3Y*
22.57%
5Y*
16.43%
10Y*
11.92%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


NextNav Inc.

Novartis AG

Return for Risk

NN vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NN
NN Risk / Return Rank: 5858
Overall Rank
NN Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
NN Sortino Ratio Rank: 5858
Sortino Ratio Rank
NN Omega Ratio Rank: 5757
Omega Ratio Rank
NN Calmar Ratio Rank: 5757
Calmar Ratio Rank
NN Martin Ratio Rank: 5959
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8989
Overall Rank
NVS Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 8787
Sortino Ratio Rank
NVS Omega Ratio Rank: 8585
Omega Ratio Rank
NVS Calmar Ratio Rank: 9090
Calmar Ratio Rank
NVS Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NN vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NextNav Inc. (NN) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NNNVSDifference

Sharpe ratio

Return per unit of total volatility

0.53

1.91

-1.39

Sortino ratio

Return per unit of downside risk

1.09

2.51

-1.42

Omega ratio

Gain probability vs. loss probability

1.14

1.33

-0.19

Calmar ratio

Return relative to maximum drawdown

0.66

3.70

-3.04

Martin ratio

Return relative to average drawdown

1.69

10.89

-9.20

NN vs. NVS - Sharpe Ratio Comparison

The current NN Sharpe Ratio is 0.53, which is lower than the NVS Sharpe Ratio of 1.91. The chart below compares the historical Sharpe Ratios of NN and NVS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


NNNVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.53

1.91

-1.39

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.89

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.61

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

0.43

-0.31

Correlation

The correlation between NN and NVS is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

NN vs. NVS - Dividend Comparison

NN has not paid dividends to shareholders, while NVS's dividend yield for the trailing twelve months is around 3.12%.


TTM20252024202320222021202020192018201720162015
NN
NextNav Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVS
Novartis AG
3.12%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Drawdowns

NN vs. NVS - Drawdown Comparison

The maximum NN drawdown since its inception was -86.54%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for NN and NVS.


Loading graphics...

Drawdown Indicators


NNNVSDifference

Max Drawdown

Largest peak-to-trough decline

-86.54%

-42.10%

-44.44%

Max Drawdown (1Y)

Largest decline over 1 year

-36.62%

-10.76%

-25.86%

Max Drawdown (5Y)

Largest decline over 5 years

-20.42%

Max Drawdown (10Y)

Largest decline over 10 years

-26.03%

Current Drawdown

Current decline from peak

-17.25%

-6.65%

-10.60%

Average Drawdown

Average peak-to-trough decline

-47.22%

-10.94%

-36.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.27%

3.66%

+10.61%

Volatility

NN vs. NVS - Volatility Comparison

NextNav Inc. (NN) has a higher volatility of 21.98% compared to Novartis AG (NVS) at 6.36%. This indicates that NN's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


NNNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.98%

6.36%

+15.62%

Volatility (6M)

Calculated over the trailing 6-month period

47.41%

14.77%

+32.64%

Volatility (1Y)

Calculated over the trailing 1-year period

60.77%

21.66%

+39.11%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

75.53%

18.51%

+57.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.53%

19.55%

+55.98%

Financials

NN vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between NextNav Inc. and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
945.00K
13.33B
(NN) Total Revenue
(NVS) Total Revenue
Values in USD except per share items